HeyJaredAngelica Ballesteros
- Indexed articles, last 90 days
- 153
- Latest publication
- Oct 2, 2026
- Outlet visibility, for insidermonkey.com
- Top 1M sites
- Earliest in this view
- Jul 8, 2026
Latest articles
Synopsys (SNPS) Bags New Multi-Billion Dollar Deals, Shares Spike (opens the original)
Read excerpt
Synopsys Inc. (NASDAQ:SNPS) grew its share price by 12.78 percent on Thursday to close at $490.54 apiece after unveiling new billion-dollar deals with Amazon and OpenAI, helping bolster its revenue growth outlook for fiscal year 2027. In separate updates, Synopsys said that it clinched a $1 billion multi-year deal with Amazon to accelerate the development of custom silicon and AI-powered products and cloud infrastructure. The agreement helped expand the chip design firm’s silicon IP business to
Accenture (ACN) Soars 15.8% as Q4 Earnings, AI Bookings Crush Disruption Fears (opens the original)
Read excerpt
Accenture PLC (NYSE:ACN) extended its winning streak to a 3rd straight day on Thursday, climbing 15.78 percent to close at $212.30 apiece, as investors cheered its strong earnings performance in the fourth quarter of fiscal year 2026, alongside the jump in new bookings that allayed fears about AI disruptions on consulting firms. In an updated report on the same day, the IT services giant said that its attributable net income surged by 40.8 percent to $1.99 billion from $1.413 billion in the same
Mattel Inc. (MAT) Spikes 36% on $6B Takeover Buzz — What’s Next For Shareholders? (opens the original)
Read excerpt
Mattel Inc. (NASDAQ:MAT) soared as much as 36 percent on Thursday as investors gobbled up its shares after reports that Authentic Brands Group is setting its sights on the company for $6 billion. The stock pared gains toward the end of the session, finishing just up by 18.8 percent at $15.04 apiece. The rally was driven primarily by an exclusive Wall Street Journal report that Authentic Brands offered to take over Mattel Inc. for $6 billion. The value, however, was just secondary. Investor inter
Despite Heavy Hedge Fund Support, Why Sellas Life Sciences (SLS) Fell 16.6% in Q3 (opens the original)
Read excerpt
Shares of Sellas Life Sciences Group Inc. (NASDAQ:SLS) nosedived by 16.6 percent in the third quarter of the year—from $14.76 on June 30 to $12.31 on Wednesday—as sentiment was dragged down by the delays and uncertainties surrounding the clinical results of its treatment candidate for acute myeloid leukemia (AML). In Wednesday’s trading alone, the stock was up by 6.95 percent, primarily driven by third-quarter window-dressing. The company has promised to report data from the phase 3 study of its
Behind Zeta Global’s (ZETA) 60.4% Rally in Q3 (opens the original)
Read excerpt
Zeta Global Holdings Corp. (NYSE:ZETA) saw its share price jump by 60.4 percent in the third quarter of the year, primarily driven by the strong performance of its Athena AI platform. Launched in March 2026, Athena AI is a superintelligent agent designed to support the operations of enterprise marketing teams. It helps convert enterprise data into predictive answers, enabling teams to identify opportunities faster, execute with precision, and prove the business impact of every decision. In June
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For insidermonkey.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.